Stefan Somlo

9PUBLICATIONS
37CO-AUTHORS
Molecular targetsFamily and household studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2026
Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease.

Zemeng Wei, Jianlei Gu, Xin Tian

|Jul 15, 2025
Glis3 is a modifier of cyst progression in autosomal dominant polycystic kidney disease.

Zemeng Wei, Jianlei Gu, Xin Tian

|May 01, 2024
Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease.

Chao Zhang, Michael Rehman, Xin Tian

|Jan 19, 2024
A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress.

Bogdan I Fedeles, Rishi Bhardwaj, Yasunobu Ishikawa

|Mar 30, 2023
The C-terminal tail of polycystin-1 suppresses cystic disease in a mitochondrial enzyme-dependent fashion.

Laura Onuchic, Valeria Padovano, Giorgia Schena

|Oct 12, 2021
Renal plasticity revealed through reversal of polycystic kidney disease in mice.

Ke Dong, Chao Zhang, Xin Tian

Pageof 2